Weight loss injections, including glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (Zepbound), have become increasingly popular for chronic weight management
The FDA uses the terms somewhat interchangeably in public communications, often grouping "compounded, counterfeit, and gray-market" products together
Semaglutide is available as a 2 mg/3 ml, 4 mg/3 ml, and 8 mg/3 ml subcutaneous injection
The medicine may be given with or without food, depending on the doctor's instructions
And because we start with smaller, carefully monitored doses, we can fine-tune your results while respecting your bodys natural rhythms